Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...

Illumina shareholders received a warning shot. In response to President Trump’s initial tariff measures, the Chinese ...

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with ...

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...